Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 2 2023

Full Issue

Viral Reservoirs Inside Patients May Be Linked To Long Covid

Microbiologist Amy Proal, quoted in NPR, says, "There's enough evidence to place viral reservoirs as one of the leading drivers of long covid." Reservoirs allow the virus to persist in the body. Also, research in Ohio showed that omicron covid was a common cause of reinfections of the virus.

NPR: Long COVID Clues Point To Viral Reservoirs As Key Target

Brent Palmer's first inkling about long COVID started in the early days of the pandemic, before the term "long COVID" even existed. Some of his friends had caught the virus while on a ski trip and returned home to Colorado with the mysterious, new illness. It was a frightening time — and an irresistible opportunity for Palmer, who studies the immune response to infectious diseases like HIV. (Stone, 5/2)

CIDRAP: Data Show Omicron Common Cause Of COVID-19 Reinfections

A study of 541 children and young adults in Ohio with two or more SARS-CoV-2 infections finds that the median interval between two infections was 229 days, and reinfection counts were higher during the Omicron era. The study is published in the Journal of the Pediatric Infectious Diseases Society. (Soucheray, 5/1)

On the covid vaccine rollout —

The Washington Post: Most Federal Covid Vaccine Mandates To End May 11

The Biden administration will end its requirements that most international travelers, federal workers and contractors, health-care workers and Head Start educators be vaccinated against the coronavirus effective on May 11 — the same day it terminates the pandemic-related public health emergency. (Diamond, 5/1)

The Boston Globe: Boston To Close Three COVID-19 Vaccination And Testing Sites

The Boston Public Health Commission will close three of its COVID-19 vaccination and testing sites on May 13, citing “a sustained decline in site utilization and patient volumes.” The three sites are located at a Boston Centers for Youth and Families facility in Hyde Park, the Josephine Fiorentino Community Center in Allston, and the Lena Park Community Development Corporation offices in Dorchester, city officials said. (Andersen, 5/1)

The Texas Tribune: Ken Paxton To Investigate COVID-19 Vaccine Makers

Long an opponent of COVID-19 safety mandates, Texas Attorney General Ken Paxton said Monday he will investigate three major pharmaceutical companies for deceptive practices, arguing that they may have misrepresented the effectiveness of vaccines and the likelihood of becoming infected after receiving a vaccine. (Barragan, 5/1)

CIDRAP: Study Of Novavax COVID Vaccine Estimates 100% Efficacy Against Hospitalizations

A post hoc analysis of a phase 3 randomized, controlled trial estimates that two doses of the Novavax (NVX-CoV2373) COVID-19 vaccine were 100% effective against hospitalization by 95 days during a period dominated by the SARS-CoV-2 Alpha variant. (Van Beusekom, 5/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF